2Firsts
June 3, 2026
According to Medical Xpress, Gamereactor, News of Bahrain and the Swedish Council for Information on Alcohol and Other Drugs (CAN), Sweden’s daily smoking rate fell to 4.8% in 2025, below the 5% threshold commonly used in public health discussions to define smoke-free status.
CAN’s latest report, Self-Reported Smoking and Snus Use 2003–2025, showed that Sweden’s daily smoking rate declined from 16% in 2003 to 4.8% in 2025. Medical Xpress reported that Sweden therefore met its smoke-free target in 2025.
The figure should be distinguished from 5.3%, which has appeared in some earlier reports and refers more broadly to overall smoking prevalence or previous statistical framing, rather than the daily smoking rate used for the smoke-free benchmark.
CAN’s report also shows that Sweden is not a low-nicotine-use country. Medical Xpress reported that although daily smoking has fallen below 5%, about one-quarter of Sweden’s population still uses nicotine daily in some form, including snus, nicotine pouches and vaping products.
CAN’s English summary said that in 2025, 5% of the population had vaped at least once in the preceding month. Most were sporadic users, while daily vaping stood at 1.9%.
On oral nicotine products, CAN said nicotine pouches were as common as traditional brown snus in the general population in 2025, but user profiles differed. Nicotine pouches were more common among women and young adults, while brown snus was more common among men and older adults.
Snus is an oral tobacco product typically placed between the upper lip and gum. Sweden secured an exemption for snus sales when it joined the European Union, making its snus market structurally different from most other EU member states.
CAN data show that daily snus users consumed around 200 tins per year between 2007 and 2018. Consumption has increased since 2019, reaching 243 tins per year in 2025.
Groups supporting tobacco harm reduction argue that Sweden’s low smoking rate is linked to the availability of smoke-free nicotine products such as snus and nicotine pouches. Medical Xpress reported that Sweden reached the sub-5% daily smoking benchmark in 2025 while still recording widespread daily nicotine use.
However, some public health organizations caution that low smoking prevalence should not be equated with the end of nicotine-related public health concerns. The Swedish Cancer Society said Sweden is still not entirely smoke-free, that smoking remains a major preventable cause of cancer in the country and that total tobacco and nicotine use remains high.
Industry observers said Sweden’s experience is becoming an important reference point in Europe’s nicotine regulation debate. On one hand, daily smoking has fallen below 5%; on the other, rising use of smoke-free nicotine products among women, young adults and snus users is shifting regulatory attention from reducing smoking alone to managing overall nicotine use.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
